Publications

Publications published since 2000 or in press from OUS - Department of Haematology

512 publications found

Publications in press

  1. Cesaro S, Pillon M, Tridello G, Aljurf M, Martino R, Schroyens W, Nozzoli C, Barba P, Faraci M, Fagioli F, Cappelli B, Cordonnier C, Al-Mohareb F, Floisand Y, Greil J, Panizzolo IS, Santarone S
    Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study of European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant (in press)
    PubMed 23222380
  2. Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM
    Cost-Effectiveness of Additional Catheter-Directed Thrombolysis for Deep Vein Thrombosis
    J Thromb Haemost (in press)
    PubMed 23452204
  3. Hornslien AG, Sandset EC, Bath PM, Wyller TB, Berge E, on Behalf of the Scandinavian Candesartan Acute Stroke Trial Study Group
    Effects of Candesartan in Acute Stroke on Cognitive Function and Quality of Life: Results From the Scandinavian Candesartan Acute Stroke Trial
    Stroke (in press)
    PubMed 23660849
  4. Iversen PO, Negaard H, Ostenstad B, Sandset PM, Kolset SO
    Evidence for long term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
    Leuk Lymphoma (in press)
    PubMed 23656198
  5. Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Gulbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Frost Andersen N, Turesson I, Waage A, Westin J
    Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase III trial
    Blood (in press)
    PubMed 23616624
  6. Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H
    Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
    Leukemia (in press)
    PubMed 23328954

Publications 2013

  1. Abildgaard U, Heimdal K (2013)
    Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review
    Eur J Obstet Gynecol Reprod Biol, 166 (2), 117-23
    PubMed 23107053
  2. Akkök CA, Haugaa H, Galgerud A, Brinch L (2013)
    Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility
    Transfus Apher Sci, 48 (1), 63-6
    PubMed 22902604
  3. Aukner C, Eide HD, Iversen PO (2013)
    Nutritional status among older residents with dementia in open versus special care units in municipal nursing homes: an observational study
    BMC Geriatr, 13, 26
    PubMed 23496975
  4. Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2013)
    Symptoms in advanced pancreatic cancer are of importance for energy intake
    Support Care Cancer, 21 (1), 219-27
    PubMed 22684989
  5. Fernandes AM, Herlofsen SR, Karlsen TA, Küchler AM, Fløisand Y, Brinchmann JE (2013)
    Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage
    PLoS One, 8 (5), e62994
    PubMed 23671648
  6. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2013)
    Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
    J Vasc Interv Radiol, 24 (1), 17-24; quiz 26
    PubMed 23176966
  7. Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B, Jacobsen EM (2013)
    Classification of stillbirths and risk factors by cause of death--a case-control study
    Acta Obstet Gynecol Scand, 92 (3), 325-33
    PubMed 23157574
  8. Holm AM, Riise GC, Hansson L, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2013)
    Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
    Bone Marrow Transplant, 48 (5), 703-7
    PubMed 23064037
  9. Moltu SJ, Strømmen K, Blakstad EW, Almaas AN, Westerberg AC, Brække K, Rønnestad A, Nakstad B, Berg JP, Veierød MB, Haaland K, Iversen PO, Drevon CA (2013)
    Enhanced feeding in very-low-birth-weight infants may cause electrolyte disturbances and septicemia--a randomized, controlled trial
    Clin Nutr, 32 (2), 207-12
    PubMed 23043722
  10. Moore KL, Kildahl-Andersen O, Kildahl-Andersen R, Tjønnfjord GE (2013)
    Uncommon adverse effect of a common medication
    Tidsskr Nor Laegeforen, 133 (2), 165
    PubMed 23344600
  11. Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2013)
    Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
    Thromb Res, 131 (2), 178-82
    PubMed 23199546
  12. Randen U, Tierens AM, Tjønnfjord GE, Delabie J (2013)
    Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns
    Am J Clin Pathol, 139 (3), 390-5
    PubMed 23429376
  13. Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
    The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
    Thromb Haemost, 109 (4), 606-13
    PubMed 23407778
  14. Sandset PM (2013)
    Mechanisms of hormonal therapy related thrombosis
    Thromb Res, 131 Suppl 1, S4-7
    PubMed 23452740
  15. Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
    [In Process Citation]
    Tidsskr Nor Laegeforen, 133 (6), 610
    PubMed 23552139
  16. Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013)
    TFPI? and TFPI? are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
    J Hematol Oncol, 6, 5
    PubMed 23320987
  17. Vojdeman FJ, Jurlander J, van't Veer M, Itälä-Remes M, Kimby E, Tjønnfjord GE, Walewski J, Kozák T, Polliack A, Montagna M, Regazzi M, Kirkby N, van Oers M, Geisler CH (2013)
    Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis
    Leuk Lymphoma, 54 (4), 790-3
    PubMed 23025267
  18. Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA (2013)
    Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
    Lancet Neurol, 12 (6), 539-45
    PubMed 23642343

Publications 2012

  1. Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B, Nordic MPD Study Group (2012)
    The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
    Bone Marrow Transplant, 47 (3), 380-6
    PubMed 21552298
  2. Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, Lancé MD, Link A, Nielsen JD, Sandset PM, Spanjersberg AJ, Spannagl M (2012)
    Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective
    Thromb Res, 129 (4), 426-33
    PubMed 22178575
  3. Bastani NE, Kostovski E, Sakhi AK, Karlsen A, Carlsen MH, Hjeltnes N, Blomhoff R, Iversen PO (2012)
    Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients
    Arch Phys Med Rehabil, 93 (12), 2223-8.e2
    PubMed 22772083
  4. Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, Lopez-Fernández M, Fijnvandraat K, European Haemophilia Treatment Standardisation Board (2012)
    Continuous infusion in haemophilia: current practice in Europe
    Haemophilia, 18 (5), 753-9
    PubMed 22530687
  5. Berentsen S, Tjønnfjord GE (2012)
    Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
    Blood Rev, 26 (3), 107-15
    PubMed 22330255
  6. Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
    Thromb Haemost, 108 (6), 1165-71
    PubMed 23015030
  7. Boon H, Kostovski E, Pirkmajer S, Song M, Lubarski I, Iversen PO, Hjeltnes N, Widegren U, Chibalin AV (2012)
    Influence of chronic and acute spinal cord injury on skeletal muscle Na+-K+-ATPase and phospholemman expression in humans
    Am J Physiol Endocrinol Metab, 302 (7), E864-71
    PubMed 22275761
  8. Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
    Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
    Br J Haematol, 157 (6), 753-61
    PubMed 22533697
  9. Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
    A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
    Thromb Res, 130 (1), 45-51
    PubMed 22217510
  10. Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2012)
    Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
    Lancet, 379 (9810), 31-8
    PubMed 22172244
  11. Enden T, Klow NE, Sandset PM (2012)
    Catheter-directed thrombolysis for acute deep vein thrombosis Reply
    Lancet, 379 (9828), 1786-1787
  12. Enden T, Sandset PM, Kløw NE (2012)
    Evidence-based practice for patients with severe venous thrombosis
    Tidsskr Nor Laegeforen, 132 (10), 1215-6
    PubMed 22669381
  13. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 47 (12), 1552-7
    PubMed 22522568
  14. Fløisand Y, Tjønnfjord G, Beiske K (2012)
    [Invasive fungal infection]
    Tidsskr Nor Laegeforen, 132 (23-24), 2618
    PubMed 23338093
  15. Frigstad SO, Jønsson V, Moum B (2012)
    [A woman in her 60s with multifactorial anaemia]
    Tidsskr Nor Laegeforen, 132 (8), 965-8
    PubMed 22562330
  16. Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB (2012)
    Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists
    Br J Haematol, 158 (6), 811-4
    PubMed 22816787
  17. Gravensteen IK, Helgadottir LB, Jacobsen EM, Sandset PM, Ekeberg Ø (2012)
    Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study
    BMC Pregnancy Childbirth, 12, 43
    PubMed 22676992
  18. Gruber FX, Lundan T, Goll R, Silye A, Mikkola I, Rekvig OP, Knuutila S, Remes K, Gedde-Dahl T, Porkka K, Hjorth-Hansen H (2012)
    BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
    Med. Oncol., 29 (1), 219-226
  19. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2012)
    The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study
    Thromb Res, 130 (1), 32-7
    PubMed 22178574
  20. Hjorth M, Hjertner Ø, Knudsen LM, Gulbrandsen N, Holmberg E, Pedersen PT, Andersen NF, Andréasson B, Billström R, Carlson K, Carlsson MS, Flogegård M, Forsberg K, Gimsing P, Karlsson T, Linder O, Nahi H, Othzén A, Swedin A, Nordic Myeloma Study Group (NMSG) (2012)
    Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
    Eur J Haematol, 88 (6), 485-96
    PubMed 22404182
  21. Holm A, Wu W, Lund-Johansen F (2012)
    Antibody array analysis of labelled proteomes: how should we control specificity?
    N Biotechnol, 29 (5), 578-85
    PubMed 21840428
  22. Holmström M, Tran HT, Holme PA (2012)
    Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience
    Haemophilia, 18 (4), 544-9
    PubMed 22348384
  23. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012)
    The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
    Lancet, 379 (9834), 2352-63
    PubMed 22632908
  24. Jacobsen AF, Sandset PM (2012)
    Venous thromboembolism associated with pregnancy and hormonal therapy
    Best Pract Res Clin Haematol, 25 (3), 319-32
    PubMed 22959548
  25. Jusufovic M, Sandset EC, Popperud TH, Solberg S, Ringstad G, Kerty E (2012)
    An unusual case of the syndrome of cervical rib with subclavian artery thrombosis and cerebellar and cerebral infarctions
    BMC Neurol, 12, 48
    PubMed 22741548
  26. Ljungman P, Locasciulli A, de Soria VG, Békássy AN, Brinch L, Espigado I, Ferrant A, Franklin IM, O'Riordan J, Rovira M, Shaw P, Einsele H, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (2012)
    Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
    Bone Marrow Transplant, 47 (9), 1217-21
    PubMed 22158388
  27. Nyquist KB, Panagopoulos I, Thorsen J, Roberto R, Wik HS, Tierens A, Heim S, Micci F (2012)
    t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia
    Br J Haematol, 157 (6), 769-71
    PubMed 22404713
  28. Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V, Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) (2012)
    Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients
    J Intern Med, 272 (5), 472-83
    PubMed 22519980
  29. Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F, Rosing J, Wasserthal-Smoller S, Martin LW, Manson JE, Lakshminarayan K, Merino JG, Lynch J (2012)
    Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy
    Stroke, 43 (4), 952-7
    PubMed 22363056
  30. Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
    Patient knowledge of late effects of acute lymphoblastic leukaemia
    Tidsskr Nor Laegeforen, 132 (18), 2052-5
    PubMed 23038194
  31. Sandset EC, Berge E (2012)
    Response to Letter by Simone Vidale Regarding Article, "Relation Between Change in Blood Pressure in Acute Stroke and Risk of Early Adverse Events and Poor Outcome"
    Stroke, 43 (12), E177
  32. Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
    Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
    Stroke, 43 (8), 2108-14
    PubMed 22627991
  33. Sandset PM (2012)
    CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
    Thromb Res, 129 Suppl 1, S97-100
    PubMed 22682144
  34. Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
    Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-?B and apoptosis mediated by a caspase-3 independent pathway
    Mol Biol Rep, 39 (12), 10089-96
    PubMed 22932941
  35. Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012)
    TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells
    PLoS One, 7 (10), e47184
    PubMed 23071754
  36. Stuchlý J, Kanderová V, Fi?er K, Cerná D, Holm A, Wu W, Hru?ák O, Lund-Johansen F, Kalina T (2012)
    An automated analysis of highly complex flow cytometry-based proteomic data
    Cytometry A, 81 (2), 120-9
    PubMed 22213549
  37. Stupar D, Eide WB, Bourne L, Hendricks M, Iversen PO, Wandel M (2012)
    The nutrition transition and the human right to adequate food for adolescents in the Cape Town metropolitan area: Implications for nutrition policy
    Food Policy, 37 (3), 199-206
  38. Thorsen J, Aamot HV, Roberto R, Tjønnfjord GE, Micci F, Heim S (2012)
    Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1
    Cancer Genet, 205 (10), 528-32
    PubMed 22944560
  39. Tjønnfjord GE, Jønsson V, Ly BE, Johannesen TB (2012)
    Familial occurrence of chronic lymphocytic leukaemia in Norway
    Tidsskr Nor Laegeforen, 132 (18), 2060-3
    PubMed 23038196
  40. Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V (2012)
    Chronic lymphocytic leukaemia in Norway--incidence and prognostic markers at diagnosis
    Tidsskr Nor Laegeforen, 132 (18), 2056-9
    PubMed 23038195
  41. Turowski G, Berge LN, Helgadottir LB, Jacobsen EM, Roald B (2012)
    A new, clinically oriented, unifying and simple placental classification system
    Placenta, 33 (12), 1026-35
    PubMed 23110739
  42. Vandvik PO, Sandset PM (2012)
    [Confusion regarding evidence-based advice]
    Tidsskr Nor Laegeforen, 132 (10), 1204
    PubMed 22669369
  43. Vetlesen A, Holme PA, Lyberg T, Kjeldsen-Kragh J (2012)
    Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation
    Transfusion, 52 (6), 1321-32
    PubMed 22084943
  44. Wang Y, Brinch L, Jebsen P, Tanbo T, Kirschner R (2012)
    A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation
    Biol Blood Marrow Transplant, 18 (5), 747-53
    PubMed 21963879
  45. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J (2012)
    Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies
    Stroke, 43 (11), 2904-9
    PubMed 22996959
  46. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study
    BMJ Open, 2 (6)
    PubMed 23144263
  47. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study
    J Thromb Haemost, 10 (5), 840-7
    PubMed 22452811
  48. Wiktor-Jedrzejczak W, Dearden C, de Wreede L, van Biezen A, Brinch L, Leblond V, Brune M, Volin L, Kazmi M, Nagler A, Schetelig J, de Witte T, Dreger P, EBMT Chronic Leukemia Working Party (2012)
    Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
    Leukemia, 26 (5), 972-6
    PubMed 22116553

Publications 2011

  1. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U (2011)
    Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy
    Thromb Res, 127 (6), 540-6
    PubMed 21435698
  2. Berg V, Lyche JL, Karlsson C, Stavik B, Nourizadeh-Lillabadi R, Hårdnes N, Skaare JU, Alestrøm P, Lie E, Ropstad E (2011)
    Accumulation and effects of natural mixtures of persistent organic pollutants (POP) in Zebrafish after two generations of exposure
    J Toxicol Environ Health A, 74 (7-9), 407-23
    PubMed 21391088
  3. Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
    Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
    Br J Haematol, 154 (2), 241-7
    PubMed 21564075
  4. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
    Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
    Leuk Lymphoma, 52 (10), 2007-9
    PubMed 21663503
  5. Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
    Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
    Eur J Haematol, 86 (5), 385-95
    PubMed 21332794
  6. Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
    Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
    J Thromb Haemost, 9 (6), 1261-3
    PubMed 21489133
  7. Haugen F, Labori KJ, Noreng HJ, Buanes T, Iversen PO, Drevon CA (2011)
    Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer
    Arch Physiol Biochem, 117 (2), 78-87
    PubMed 21457003
  8. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    The association of inherited thrombophilia and intrauterine fetal death: a case-control study
    Blood Coagul Fibrinolysis, 22 (8), 651-6
    PubMed 22198364
  9. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    Incidence and risk factors of fetal death in Norway: a case-control study
    Acta Obstet Gynecol Scand, 90 (4), 390-7
    PubMed 21306337
  10. Iversen PO, Hoisaether EA, Morseth M, Herselman M (2011)
    Diverging opinions of supplementation programmes between mothers of small children and staff at primary health clinics in the Western Cape Province of South Africa
    Public Health Nutr., 14 (5), 923-930
  11. Jønsson V, Awan H, Nyquist E, Maisenhølder M, Johannesen TB, Ly B, Tjønnfjord GE (2011)
    Familial Hodgkin's lymphoma in Scandinavia
    In Vivo, 25 (3), 431-7
    PubMed 21576419
  12. Karlsen TA, Mirtaheri P, Shahdadfar A, Fløisand Y, Brinchmann JE (2011)
    Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells
    J Cell Biochem, 112 (2), 684-93
    PubMed 21268090
  13. Knudsen E, Iversen PO, Bøyum A, Seierstad T, Nicolaysen G, Benestad HB (2011)
    G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells
    Eur J Haematol, 87 (4), 302-11
    PubMed 21623923
  14. Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
    Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
    Blood Coagul Fibrinolysis, 22 (4), 254-9
    PubMed 21297449
  15. Krarup LH, Sandset EC, Sandset PM, Berge E (2011)
    D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
    Acta Neurol Scand, 124 (1), 40-4
    PubMed 20726843
  16. Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2011)
    Reduced platelet function and role of drugs in acute gastrointestinal bleeding
    Basic Clin Pharmacol Toxicol, 108 (3), 194-201
    PubMed 21118353
  17. Kvam AK, Fayers PM, Wisloff F (2011)
    Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
    Eur J Haematol, 87 (4), 330-7
    PubMed 21668504
  18. Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, Holme PA, Holmström M, Johnsson H, Joutsi-Korhonen L, Sandset PM (2011)
    Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia
    Semin Thromb Hemost, 37 (3), 328-36
    PubMed 21455867
  19. Lassila R, Holme PA, Landorph A, Petrini P, Onundarson PT, Hillarp A (2011)
    Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease
    Semin Thromb Hemost, 37 (5), 495-502
    PubMed 22102192
  20. Lyche JL, Nourizadeh-Lillabadi R, Karlsson C, Stavik B, Berg V, Skåre JU, Alestrøm P, Ropstad E (2011)
    Natural mixtures of POPs affected body weight gain and induced transcription of genes involved in weight regulation and insulin signaling
    Aquat Toxicol, 102 (3-4), 197-204
    PubMed 21356182
  21. Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA, UK Collaborators of IST (2011)
    Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial
    PLoS One, 6 (3), e16988
    PubMed 21445242
  22. Möllgård L, Saft L, Treppendahl MB, Dybedal I, Nørgaard JM, Astermark J, Ejerblad E, Garelius H, Dufva IH, Jansson M, Jädersten M, Kjeldsen L, Linder O, Nilsson L, Vestergaard H, Porwit A, Grønbæk K, Hellström-Lindberg E (2011)
    Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
    Haematologica, 96 (7), 963-71
    PubMed 21719884
  23. Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
    Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
    Leuk Lymphoma, 52 (6), 1157-9
    PubMed 21463121
  24. Nilsson-Ehle H, Birgegård G, Samuelsson J, Antunovic P, Astermark J, Garelius H, Engström LM, Kjeldsen L, Nilsson L, Olsson A, Skov-Holm M, Wallvik J, Gulbrandsen N, Hellström-Lindberg E (2011)
    Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ?120?g/L with darbepoetin alfa?±?filgrastim or erythrocyte transfusions
    Eur J Haematol, 87 (3), 244-52
    PubMed 21623919
  25. Nyquist KB, Thorsen J, Zeller B, Haaland A, Trøen G, Heim S, Micci F (2011)
    Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)
    Cancer Genet, 204 (3), 147-52
    PubMed 21504714
  26. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
    An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
    J Virol, 85 (13), 6557-66
    PubMed 21490090
  27. Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A et al. (2011)
    Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
    Trials, 12, 252
    PubMed 22129158
  28. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
    The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
    Lancet, 377 (9767), 741-50
    PubMed 21316752
  29. Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Bjerrum OW, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A et al. (2011)
    Combination of pegylated IFN-?2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
    Blood, 118 (12), 3228-35
    PubMed 21685374
  30. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2011)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    PubMed 21165555
  31. Slaastad H, Wu W, Goullart L, Kanderova V, Tjønnfjord G, Stuchly J, Kalina T, Holm A, Lund-Johansen F (2011)
    Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins
    Proteomics, 11 (23), 4578-82
    PubMed 21956872
  32. Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, Sletten M, Sandset PM, Iversen N (2011)
    Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
    BMC Cancer, 11, 357
    PubMed 21849050
  33. Tangen JM, Jaworska A, Mattsson H (2011)
    The Fukushima accident--health consequences
    Tidsskr Nor Laegeforen, 131 (23), 2342-3
    PubMed 22139113
  34. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2011)
    Protein C mutation (A267T) results in ER retention and unfolded protein response activation
    PLoS One, 6 (8), e24009
    PubMed 21901152
  35. Toleikyte I, Retterstøl K, Leren TP, Iversen PO (2011)
    Pregnancy outcomes in familial hypercholesterolemia: a registry-based study
    Circulation, 124 (15), 1606-14
    PubMed 21911783
  36. Tran HT, Tjønnfjord GE, Paus A, Holme PA (2011)
    rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency
    Haemophilia, 17 (5), 764-70
    PubMed 21707871
  37. Westerberg AC, Schei R, Henriksen C, Smith L, Veierød MB, Drevon CA, Iversen PO (2011)
    Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid
    Acta Paediatr, 100 (1), 47-52
    PubMed 20624152
  38. Wik HS, Enden TR, Jacobsen AF, Sandset PM (2011)
    Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity
    J Thromb Haemost, 9 (10), 1931-6
    PubMed 21848904

Publications 2010

  1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    PubMed 20844564
  2. Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K, European Haemophilia Therapy Standardisation Board (2010)
    Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
    Haemophilia, 16 (5), 747-66
    PubMed 20398077
  3. Austbø L, Røed KH, Dolvik NI, Skretting G (2010)
    Identification of differentially expressed genes associated with osteochondrosis in standardbred horses using RNA arbitrarily primed PCR
    Anim Biotechnol, 21 (2), 135-9
    PubMed 20379890
  4. Awan H, Jønsson V, Johannesen TB, Ly B, Tjønnfjord GE (2010)
    Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders
    Transl Oncogenomics, 4, 1-9
    PubMed 21566766
  5. Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE (2010)
    High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
    Blood, 116 (17), 3180-4
    PubMed 20634373
  6. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M, Sandset PM (2010)
    The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study
    Thromb Res, 125 (5), e222-7
    PubMed 20051285
  7. Bjornaas MA, Jacobsen EM, Jacobsen D (2010)
    Nonfatal self-poisoning with LMW heparin and the use of antidote
    Thromb Res, 126 (5), e403-5
    PubMed 20870279
  8. Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
    Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
    J Thromb Haemost, 8 (5), 1130-2
    PubMed 20149077
  9. Di Niro R, Mesin L, Raki M, Zheng NY, Lund-Johansen F, Lundin KE, Charpilienne A, Poncet D, Wilson PC, Sollid LM (2010)
    Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa
    J Immunol, 185 (9), 5377-83
    PubMed 20935207
  10. Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE (2010)
    Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA)
    J Magn Reson Imaging, 31 (2), 416-24
    PubMed 20099355
  11. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    PubMed 20387168
  12. Ghanima W, Holme PA, Tjønnfjord GE (2010)
    [Immune thrombocytopenia--pathophysiology and treatment]
    Tidsskr Nor Laegeforen, 130 (21), 2120-3
    PubMed 21052113
  13. Gimsing P, Carlson K, Turesson I, Fayers P, Waage A, Vangsted A, Mylin A, Gluud C, Juliusson G, Gregersen H, Hjorth-Hansen H, Nesthus I, Dahl IM, Westin J, Nielsen JL, Knudsen LM, Ahlberg L, Hjorth M, Abildgaard N, Andersen NF, Linder O, Wisløff F (2010)
    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
    Lancet Oncol, 11 (10), 973-82
    PubMed 20863761
  14. Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E (2010)
    Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
    Br J Haematol, 150 (3), 293-302
    PubMed 20497178
  15. Ha L, Hauge T, Iversen PO (2010)
    Body composition in older acute stroke patients after treatment with individualized, nutritional supplementation while in hospital
    BMC Geriatr, 10, 75
    PubMed 20955603
  16. Ha L, Hauge T, Spenning AB, Iversen PO (2010)
    Individual, nutritional support prevents undernutrition, increases muscle strength and improves QoL among elderly at nutritional risk hospitalized for acute stroke: a randomized, controlled trial
    Clin Nutr, 29 (5), 567-73
    PubMed 20176418
  17. Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G (2010)
    Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
    Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
    PubMed 20032264
  18. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    PubMed 20539915
  19. Iversen PO, Wisløff F, Gulbrandsen N (2010)
    Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support
    Clin Nutr, 29 (4), 488-91
    PubMed 20044183
  20. Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
    Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
    J Thromb Haemost, 8 (11), 2443-9
    PubMed 20735725
  21. Jensen K, Schaffer L, Olstad OK, Bechensteen AG, Hellebostad M, Tjønnfjord GE, Kierulf P, Gautvik KM, Osnes LT (2010)
    Striking decrease in the total precursor B-cell compartment during early childhood as evidenced by flow cytometry and gene expression changes
    Pediatr Hematol Oncol, 27 (1), 31-45
    PubMed 20121553
  22. Johnsen HE, Klausen TW, Boegsted M, Lenhoff S, Gimsing P, Christiansen I, Gedde-Dahl T, Lindås R, Mellqvist UH, Nordic Myeloma Study Group (2010)
    Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group
    Clin Lymphoma Myeloma Leuk, 10 (4), 290-6
    PubMed 20709667
  23. Jønsson V, Tjønnfjord GE, Johannesen TB, Ly B, Olsen JH, Yuille M (2010)
    Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order
    In Vivo, 24 (1), 85-95
    PubMed 20133982
  24. Kardel KR, Henriksen T, Iversen PO (2010)
    No effect of energy supply during childbirth on delivery outcomes in nulliparous women: a randomised, double-blind, placebo-controlled trial
    J Obstet Gynaecol, 30 (3), 248-52
    PubMed 20373924
  25. Kostovski E, Iversen PO, Hjeltnes N (2010)
    [Complications of chronic spinal cord injury]
    Tidsskr Nor Laegeforen, 130 (12), 1242-5
    PubMed 20567276
  26. Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J, Ketterer N, Catovsky D, Ethell M, Matutes E, Dearden CE (2010)
    Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
    Br J Haematol, 149 (6), 907-10
    PubMed 20201944
  27. Kvam AK, Fayers P, Wisloff F (2010)
    What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
    Eur J Haematol, 84 (4), 345-53
    PubMed 20041946
  28. Kvam AK, Wisløff F, Fayers PM (2010)
    Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
    Health Qual Life Outcomes, 8, 79
    PubMed 20678240
  29. Lyche JL, Nourizadeh-Lillabadi R, Almaas C, Stavik B, Berg V, Skåre JU, Alestrøm P, Ropstad E (2010)
    Natural mixtures of persistent organic pollutants (POP) increase weight gain, advance puberty, and induce changes in gene expression associated with steroid hormones and obesity in female zebrafish
    J Toxicol Environ Health A, 73 (15), 1032-57
    PubMed 20526952
  30. Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM (2010)
    Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy
    Blood Coagul Fibrinolysis, 21 (6), 516-21
    PubMed 20453636
  31. Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I (2010)
    The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease
    Pathophysiol Haemost Thromb, 37 (2-4), 98-103
    PubMed 21555871
  32. Perry D, Berntorp E, Tait C, Dolan G, Holme PA, Laffan M, Lassila R, Mumford A, Pasi J, Wilde J, Will A, Yee TT (2010)
    FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
    Haemophilia, 16 (1), 80-9
    PubMed 19780845
  33. Ruland CM, Holte HH, Røislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaløy SO, Hasund L, Ellison MC (2010)
    Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
    J Am Med Inform Assoc, 17 (4), 403-10
    PubMed 20595307
  34. Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2010)
    Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)
    Int J Stroke, 5 (5), 423-7
    PubMed 20854630
  35. Sandset PM (2010)
    Immunobiology of heparin-induced thrombocytopenia
    Curr Top Microbiol Immunol, 341, 193-202
    PubMed 20369319
  36. Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
    Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
    Thromb Res, 126 (3), e232-4
    PubMed 20553950
  37. Sandset PM, Francis C (2010)
    Thrombosis Research--affiliation with the European Thrombosis Research Organization (ETRO)
    Thromb Res, 125 (1), 1
    PubMed 20171348
  38. Semaeva E, Tenstad O, Skavland J, Enger M, Iversen PO, Gjertsen BT, Wiig H (2010)
    Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation
    J Immunol, 184 (8), 4547-56
    PubMed 20237290
  39. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    PubMed 20384870
  40. Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010)
    Functional characterization of polymorphisms in the human TFPI gene
    Biochem Biophys Res Commun, 397 (1), 106-11
    PubMed 20519147
  41. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    PubMed 20348994
  42. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    PubMed 20348990
  43. Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N (2010)
    Overexpression of both TFPI? and TFPI? induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells
    Mol Carcinog, 49 (11), 951-63
    PubMed 20886581
  44. Tangen JM, Fløisand Y, Haukås E, Naess IA, Skjelbakken T, Stapnes C, Tjønnfjord GE (2010)
    [Survival in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 130 (17), 1710-3
    PubMed 20835280
  45. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2010)
    Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport
    BMC Cell Biol, 11, 67
    PubMed 20815936
  46. Tjeldhorn L, Sandset PM, Haugbro K, Skretting G (2010)
    Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis
    Thromb Res, 125 (3), 230-4
    PubMed 19535131
  47. Westerberg AC, Henriksen C, Ellingvåg A, Veierød MB, Júlíusson PB, Nakstad B, Aurvåg AK, Rønnestad A, Grønn M, Iversen PO, Drevon CA (2010)
    First year growth among very low birth weight infants
    Acta Paediatr, 99 (4), 556-62
    PubMed 20096031
  48. Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R (2010)
    Interstitial fluid: the overlooked component of the tumor microenvironment?
    Fibrogenesis Tissue Repair, 3, 12
    PubMed 20653943
  49. Waage A, Gimsing P, Fayers P, Abildgaard N, Ahlberg L, Björkstrand B, Carlson K, Dahl IM, Forsberg K, Gulbrandsen N, Haukås E, Hjertner O, Hjorth M, Karlsson T, Knudsen LM, Nielsen JL, Linder O, Mellqvist UH, Nesthus I, Rolke J, Strandberg M, Sørbø JH, Wisløff F, Juliusson G, Turesson I et al. (2010)
    Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Blood, 116 (9), 1405-12
    PubMed 20448107

Publications 2009

  1. Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A (2009)
    Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin
    Thromb Res, 124 (3), 262-7
    PubMed 19162303
  2. Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O (2009)
    Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells
    Transfusion, 49 (2), 354-61
    PubMed 18980622
  3. Andresen PA, Heimdal K, Aaberg K, Eklo K, Ariansen S, Silye A, Fausa O, Aabakken L, Aretz S, Eide TJ, Gedde-Dahl T (2009)
    APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
    J Cancer Res Clin Oncol, 135 (10), 1463-70
    PubMed 19444466
  4. Astermark J, Negrier C, Hermans C, Holme PA, Klamroth R, Kotsi P, de Moerloose P, Pasi J, Rocino A, von Depka M, Windyga J, Ludlam CA, Interdisciplinary Working Group IDWG (2009)
    European curriculum for thrombosis and haemostasis
    Haemophilia, 15 (1), 337-44
    PubMed 19149857
  5. Berentsen S, Sundic T, Hervig T, Tjønnfjord GE (2009)
    [Autoimmune hemolytic anemia]
    Tidsskr Nor Laegeforen, 129 (21), 2226-31
    PubMed 19898570
  6. Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E, Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group (2009)
    UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
    Br J Haematol, 147 (1), 22-42
    PubMed 19673884
  7. Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P (2009)
    Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
    Clin Exp Immunol, 157 (3), 400-7
    PubMed 19664149
  8. Enden T, Garratt AM, Kløw NE, Sandset PM (2009)
    Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire
    Scand J Caring Sci, 23 (2), 369-74
    PubMed 19068041
  9. Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVenT study group (2009)
    Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency
    J Thromb Haemost, 7 (8), 1268-75
    PubMed 19422443
  10. Haram K, Svendsen E, Abildgaard U (2009)
    The HELLP syndrome: clinical issues and management. A Review
    BMC Pregnancy Childbirth, 9, 8
    PubMed 19245695
  11. Henriksen C, Westerberg AC, Rønnestad A, Nakstad B, Veierød MB, Drevon CA, Iversen PO (2009)
    Growth and nutrient intake among very-low-birth-weight infants fed fortified human milk during hospitalisation
    Br J Nutr, 102 (8), 1179-86
    PubMed 19445820
  12. Holme PA, Glomstein A, Grønhaug S, Tjønnfjord GE (2009)
    Home treatment with bypassing products in inhibitor patients: a 7.5-year experience
    Haemophilia, 15 (3), 727-32
    PubMed 19320748
  13. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
    Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
    Transl Oncol, 2 (4), 242-6
    PubMed 19956385
  14. Kardel KR, Johansen B, Voldner N, Iversen PO, Henriksen T (2009)
    Association between aerobic fitness in late pregnancy and duration of labor in nulliparous women
    Acta Obstet Gynecol Scand, 88 (8), 948-52
    PubMed 19562561
  15. Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
    Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
    Eur J Haematol, 83 (4), 279-89
    PubMed 19558508
  16. Micci F, Panagopoulos I, Haugom L, Andersen HK, Tjønnfjord GE, Beiske K, Heim S (2009)
    t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia
    Cancer Lett, 277 (2), 205-11
    PubMed 19168282
  17. Michalsen S, Schrumpf E, Beiske K, Tierens A, Stenberg V, Tjønnfjord GE (2009)
    [Large granular lymphocytic leukaemia]
    Tidsskr Nor Laegeforen, 129 (11), 1098-102
    PubMed 19488091
  18. Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, Hjorth-Hansen H, Höglund M, Kovanen P, Laurinolli T, Liesveld J, Paquette R, Pinilla-Ibarz J, Rauhala A, Shah N, Simonsson B, Sinisalo M, Steegmann JL, Stenke L, Porkka K (2009)
    Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    Leukemia, 23 (8), 1398-405
    PubMed 19295545
  19. Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, Iversen PO (2009)
    Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
    Leukemia, 23 (1), 162-9
    PubMed 18800145
  20. Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, Iversen PO (2009)
    Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
    Leuk Lymphoma, 50 (6), 998-1004
    PubMed 19373600
  21. Nourizadeh-Lillabadi R, Lyche JL, Almaas C, Stavik B, Moe SJ, Aleksandersen M, Berg V, Jakobsen KS, Stenseth NC, Skåre JU, Alestrøm P, Ropstad E (2009)
    Transcriptional regulation in liver and testis associated with developmental and reproductive effects in male zebrafish exposed to natural mixtures of persistent organic pollutants (POP)
    J Toxicol Environ Health A, 72 (3-4), 112-30
    PubMed 19184727
  22. Rand-Hendriksen S, Lundby R, Tjeldhorn L, Andersen K, Offstad J, Semb SO, Smith HJ, Paus B, Geiran O (2009)
    Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome
    Eur J Hum Genet, 17 (10), 1222-30
    PubMed 19293838
  23. Rehn TA, Borge BA, Lunde PK, Munkvik M, Sneve ML, Grøndahl F, Aronsen JM, Sjaastad I, Prydz K, Kolset SO, Wiig H, Sejersted OM, Iversen PO (2009)
    Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats
    Am J Physiol Regul Integr Comp Physiol, 297 (1), R26-33
    PubMed 19339678
  24. Reseland JE, Reppe S, Olstad OK, Hjorth-Hansen H, Brenne AT, Syversen U, Waage A, Iversen PO (2009)
    Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma
    Eur J Haematol, 83 (5), 460-70
    PubMed 19572994
  25. Sandset PM, Francis C (2009)
    Thrombosis Research: Introduction of e-pages
    Thromb Res, 124 (3), 251
    PubMed 19596224
  26. Sandset PM, Francis C, Key N (2009)
    Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Thromb Res, 124 (5), 515
    PubMed 19837232
  27. Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
    Mechanisms of thrombosis related to hormone therapy
    Thromb Res, 123 Suppl 2, S70-3
    PubMed 19217481
  28. Sioud M, Fløisand Y (2009)
    NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
    J Leukoc Biol, 85 (6), 939-46
    PubMed 19244164
  29. Skretting G, Lien T, Sandset PM, Iversen N (2009)
    Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability
    Thromb Res, 123 (6), 851-5
    PubMed 19007969
  30. Slot KB, Berge E (2009)
    Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement
    J Stroke Cerebrovasc Dis, 18 (1), 17-22
    PubMed 19110139
  31. Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M, Oxfordshire Community Stroke Project, Lothian Stroke Register, International Stroke Trial (UK) (2009)
    Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts
    Stroke, 40 (5), 1585-9
    PubMed 19265057
  32. Slot KB, Murray V, Boysen G, Berge E (2009)
    Thrombolytic treatment for stroke in the Scandinavian countries
    Acta Neurol Scand, 120 (4), 270-6
    PubMed 19456310
  33. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    PubMed 19284496
  34. Sørby R, Austbø L, Press CM, Skretting G, Landsverk T, Espenes A (2009)
    PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie
    PLoS One, 4 (9), e6885
    PubMed 19727393
  35. Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
    Age and stress related phenotypical changes in bone marrow CD34+ cells
    Scand J Clin Lab Invest, 69 (1), 79-84
    PubMed 18836945
  36. Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P (2009)
    Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases
    Acta Haematol, 122 (1), 11-6
    PubMed 19641300
  37. Vik A, Holme PA, Singh K, Dorenberg E, Nordhus KC, Kumar S, Hansen JB (2009)
    Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities
    Cardiovasc Intervent Radiol, 32 (5), 980-7
    PubMed 19641959
  38. Wu W, Slåstad H, de la Rosa Carrillo D, Frey T, Tjønnfjord G, Boretti E, Aasheim HC, Horejsi V, Lund-Johansen F (2009)
    Antibody array analysis with label-based detection and resolution of protein size
    Mol Cell Proteomics, 8 (2), 245-57
    PubMed 18796702

Publications 2008

  1. Austbø L, Kampmann A, Müller-Ladner U, Neumann E, Olsaker I, Skretting G (2008)
    Identification of differentially expressed genes in ileal Peyer's patch of scrapie-infected sheep using RNA arbitrarily primed PCR
    BMC Vet Res, 4, 12
    PubMed 18373840
  2. Benestad HB, Wisløff F (2008)
    [Research ethics and University of Oslo]
    Tidsskr Nor Laegeforen, 128 (15), 1683-4
    PubMed 18704143
  3. Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
    [Allogeneic stem cell transplantation in acute myelogenous leukemia]
    Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
    PubMed 18704137
  4. Crowther-Swanepoel D, Wild R, Sellick G, Dyer MJ, Mauro FR, Cuthbert RJ, Jonsson V, Matutes E, Dearden C, Wiley J, Fuller S, Catovsky D, Houlston RS (2008)
    Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL
    Blood, 111 (12), 5691-3
    PubMed 18424666
  5. Dahm AE, Sandset PM, Rosendaal FR (2008)
    The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
    J Thromb Haemost, 6 (2), 393-5
    PubMed 18045239
  6. Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008)
    Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
    BJOG, 115 (6), 773-9
    PubMed 18355366
  7. Eilertsen AL, Sandvik L, Steinsvik B, Sandset PM (2008)
    Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers
    J Thromb Haemost, 6 (6), 928-34
    PubMed 18394014
  8. Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
    [Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 128 (22), 2563-6
    PubMed 19023351
  9. Fløisand Y, Normann AP, Heim S, Lund-Johansen F, Tjønnfjord GE (2008)
    High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia
    Scand J Clin Lab Invest, 68 (2), 93-8
    PubMed 17852828
  10. Furset G, Fløisand Y, Sioud M (2008)
    Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
    Immunology, 123 (2), 263-71
    PubMed 17725606
  11. Ha L, Iversen PO, Hauge T (2008)
    [Nutrition for elderly acute stroke patients]
    Tidsskr Nor Laegeforen, 128 (17), 1946-50
    PubMed 18787570
  12. Haga HJ, Jacobsen EM, Peen E (2008)
    Incidence of thromboembolic events in patients with primary Sjögren's syndrome
    Scand J Rheumatol, 37 (2), 127-9
    PubMed 18415770
  13. Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
    [Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
    Tidsskr Nor Laegeforen, 128 (21), 2440-2
    PubMed 19096466
  14. Holme PA, Michelsen AE (2008)
    [A 40-year old woman with dizziness and vomiting]
    Tidsskr Nor Laegeforen, 128 (12), 1413-5
    PubMed 18584769
  15. Iversen PO, Ukrainchenko E, Afanasyev B, Hulbekkmo K, Choukah A, Gulbrandsen N, Wisløff F, Tangen JM (2008)
    Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia
    Leuk Lymphoma, 49 (10), 1916-24
    PubMed 18949615
  16. Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
    Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study
    Am J Obstet Gynecol, 198 (2), 233.e1-7
    PubMed 17997389
  17. Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
    Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
    J Thromb Haemost, 6 (6), 905-12
    PubMed 18363820
  18. Johannesen TB, Ly B, Samuelsen SO, Tjønnfjord GE, Jønsson V (2008)
    [A new study of chronic lymphatic leukemia in Norway]
    Tidsskr Nor Laegeforen, 128 (6), 713
    PubMed 18337855
  19. Jädersten M, Malcovati L, Dybedal I, Della Porta MG, Invernizzi R, Montgomery SM, Pascutto C, Porwit A, Cazzola M, Hellström-Lindberg E (2008)
    Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
    J Clin Oncol, 26 (21), 3607-13
    PubMed 18559873
  20. Jønsson V, Samuelsen SO, Tjønnfjord G, Johannesen T (2008)
    Looking for CLL genes
    Leuk Lymphoma, 49 (1), 10-1
    PubMed 18203003
  21. Jønsson V, Tjønnfjord GE, Johannesen TB, Samuelsen SO, Ly B (2008)
    Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders
    Transl Oncogenomics, 3, 15-20
    PubMed 21566740
  22. Kolstad A, Tjønnfjord G, Jønsson V (2008)
    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT
    Bone Marrow Transplant, 42 (6), 427-8
    PubMed 18587433
  23. Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008)
    Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
    Clin Exp Immunol, 152 (1), 57-63
    PubMed 18241231
  24. Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, IRIS (International Randomized Interferon vs STI571) Study Group (2008)
    Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
    Blood, 111 (8), 4022-8
    PubMed 18256322
  25. Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
    Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
    J Am Coll Cardiol, 51 (6), 674-6
    PubMed 18261689
  26. Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J, Nordic Myeloma Study Group (2008)
    Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone
    Cancer, 112 (1), 129-35
    PubMed 17973267
  27. Negaard HF, Iversen PO, Ostenstad B, Mowinckel MC, Sandset PM (2008)
    Increased acquired activated protein C resistance in unselected patients with hematological malignancies
    J Thromb Haemost, 6 (9), 1482-7
    PubMed 18573186
  28. Negaard HF, Iversen PO, Østenstad B, Iversen N, Holme PA, Sandset PM (2008)
    Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor
    Thromb Haemost, 99 (6), 1040-8
    PubMed 18521506
  29. Olsen AL, Johannesen TB, Ly B, Samuelsen SO, Tjonnfjord G, Jonsson V (2008)
    Pleiotropy in families with chronic lymphocytic leukemia
    Salud Cienc., 15 (8), 1236-+
  30. Piehler AP, Gulbrandsen N, Kierulf P, Urdal P (2008)
    Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population
    Clin Chem, 54 (11), 1823-30
    PubMed 18801937
  31. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P et al. (2008)
    Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
    Trials, 9, 37
    PubMed 18559104
  32. Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G, IST-3 Collaborative Group (2008)
    EPITHET--where next?
    Lancet Neurol, 7 (7), 570-1; author reply 571-3
    PubMed 18565447
  33. Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L (2008)
    [High-dose treatment of systemic AL-amyloidosis with autologous stem cell support]
    Tidsskr Nor Laegeforen, 128 (12), 1392-6
    PubMed 18552900
  34. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P, Oxfordshire Community Stroke Project, the International Stroke Trial (UK), Lothian Stroke Register (2008)
    Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
    BMJ, 336 (7640), 376-9
    PubMed 18230644
  35. Slot KB, Berge E, Wardlaw J (2008)
    Haemorrhagic transformation of a recent silent cerebral infarct during thrombolytic stroke treatment
    BMJ Case Rep, 2008, bcr0620080266
    PubMed 21716819
  36. Stamnaes J, Fleckenstein B, Lund-Johansen F, Sollid LM (2008)
    The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2
    Scand J Immunol, 68 (5), 534-42
    PubMed 18803608
  37. Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A, Koza V, Kienast J, Niederwieser D, de Witte T, Ruutu T, complications subcommittee of the Chronic Leukemia Working Party (2008)
    The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 42 (11), 739-42
    PubMed 18724394
  38. Tangen JM, Fløisand Y, Foss-Abrahamsen J, Haukås E, Naess IA, Skjelbakken T (2008)
    [Survival in adults with acute myelogenous leukemia]
    Tidsskr Nor Laegeforen, 128 (10), 1164-7
    PubMed 18480864
  39. van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2008)
    Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
    J Thromb Haemost, 6 (2), 346-51
    PubMed 18067603
  40. Wester T, Jørgensen JJ, Stranden E, Sandbaek G, Tjønnfjord G, Bay D, Kollerøs D, Kroese AJ, Brinchmann JE (2008)
    Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study
    Scand J Surg, 97 (1), 56-62
    PubMed 18450207
  41. Aasbrenn M, Langmark F, Wisløff F (2008)
    [Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?]
    Tidsskr Nor Laegeforen, 128 (23), 2712-4
    PubMed 19079417

Publications 2007

  1. Abildgaard U (2007)
    Antithrombin--early prophecies and present challenges
    Thromb Haemost, 98 (1), 97-104
    PubMed 17597998
  2. Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J (2007)
    Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
    Vox Sang, 93 (1), 42-8
    PubMed 17547564
  3. Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2007)
    Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
    Thromb Res, 120 (1), 21-7
    PubMed 16914186
  4. Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM (2007)
    Hormone therapy and raloxifene reduce the coagulation inhibitor potential
    Blood Coagul Fibrinolysis, 18 (5), 455-60
    PubMed 17581320
  5. Andresen PA, Johansen T, Eide TJ, Gedde-Dahl T (2007)
    Gene symbol: APC
    Hum Genet, 121 (2), 288
    PubMed 17598199
  6. Austbø L, Espenes A, Olsaker I, Press CM, Skretting G (2007)
    Increased PrP mRNA expression in lymphoid follicles of the ileal Peyer's patch of sheep experimentally exposed to the scrapie agent
    J Gen Virol, 88 (Pt 7), 2083-90
    PubMed 17554044
  7. Berentsen S, Beiske K, Tjønnfjord GE (2007)
    Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy
    Hematology, 12 (5), 361-70
    PubMed 17891600
  8. Berentsen S, Ulvestad E, Tjønnfjord GE (2007)
    B-lymphocytes as targets for therapy in chronic cold agglutinin disease
    Cardiovasc Hematol Disord Drug Targets, 7 (3), 219-27
    PubMed 17896962
  9. Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
    The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
    Stroke, 38 (3), 1069-71
    PubMed 17290027
  10. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group (2007)
    An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
    Eur J Cancer, 43 (11), 1670-8
    PubMed 17574838
  11. Dahlqvist J, Klar J, Hausser I, Anton-Lamprecht I, Pigg MH, Gedde-Dahl T, Gånemo A, Vahlquist A, Dahl N (2007)
    Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis
    J Med Genet, 44 (10), 615-20
    PubMed 17557927
  12. Dalgaard J, Fløisand Y, Stenersen M, Egeland T, Brinch L (2007)
    [Non-myeloablative allogeneic stem cell transplantation]
    Tidsskr Nor Laegeforen, 127 (6), 721-4
    PubMed 17363982
  13. Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM (2007)
    Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system
    Thromb Haemost, 97 (6), 938-43
    PubMed 17549295
  14. Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM (2007)
    Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis
    Thromb Res, 120 (3), 371-9
    PubMed 17156824
  15. Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM (2007)
    Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
    Am Heart J, 154 (5), 808-14
    PubMed 17967583
  16. Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
    A VH4-34+ myeloma protein with weak autoreactivity
    Haematologica, 92 (5), 690-3
    PubMed 17488696
  17. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O, Barbui T (2007)
    Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
    Blood, 110 (4), 1178-83
    PubMed 17440049
  18. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Ross S, Sandset PM (2007)
    D-dimer level is associated with the extent of pulmonary embolism
    Thromb Res, 120 (2), 281-8
    PubMed 17030057
  19. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM (2007)
    The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE
    J Intern Med, 261 (1), 74-81
    PubMed 17222170
  20. Ghanima W, Nielssen BE, Holmen LO, Witwit A, Al-Ashtari A, Sandset PM (2007)
    Multidetector computed tomography (MDCT) in the diagnosis of pulmonary embolism: interobserver agreement among radiologists with varied levels of experience
    Acta Radiol, 48 (2), 165-70
    PubMed 17354136
  21. Ghanima W, Sandset PM (2007)
    Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE)
    Thromb Res, 120 (4), 471-6
    PubMed 17161451
  22. Ghanima W, Sandset PM (2007)
    Risk stratification of pulmonary embolism by computed tomography
    J Intern Med, 262 (6), 702
    PubMed 17944881
  23. Grövdal M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Wallvik J, Tangen JM, Oberg G, Jacobsen SE, Hokland P, Porwit A, Hellström-Lindberg E (2007)
    Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome
    Clin Cancer Res, 13 (23), 7107-12
    PubMed 18056190
  24. Holme PA (2007)
    [Deficient thrombosis prophylaxis]
    Tidsskr Nor Laegeforen, 127 (9), 1176
    PubMed 17479132
  25. Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joø GB, Godal HC, Skjønsberg OH (2007)
    Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells
    Thromb Haemost, 97 (5), 822-9
    PubMed 17479194
  26. Johannessen MK, Skretting G, Ytrehus B, Røed KH (2007)
    Neonatal growth cartilage: equine tissue specific gene expression
    Biochem Biophys Res Commun, 354 (4), 975-80
    PubMed 17276390
  27. Jønsson V, Tjønnfjord G, Samuelsen SO, Johannesen T, Olsen J, Sellick G, Houlston R, Yuille M, Catovsky D (2007)
    Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease
    Leuk Lymphoma, 48 (12), 2387-96
    PubMed 18067015
  28. Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J (2007)
    Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
    Blood, 109 (8), 3369-76
    PubMed 17158235
  29. Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F (2007)
    Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
    Br J Haematol, 136 (1), 131-7
    PubMed 17092306
  30. Liestøl S, Sandset PM, Mowinckel MC, Wisløff F (2007)
    Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
    J Thromb Haemost, 5 (11), 2204-10
    PubMed 17958739
  31. Micci F, Panagopoulos I, Tjønnfjord GE, Kolstad A, Delabie J, Beiske K, Heim S (2007)
    Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies
    Virchows Arch, 450 (5), 559-65
    PubMed 17406891
  32. Nicolaysen A, Gammelsaeter R, Storm-Mathisen J, Gundersen V, Iversen PO (2007)
    The components required for amino acid neurotransmitter signaling are present in adipose tissues
    J Lipid Res, 48 (10), 2123-32
    PubMed 17600303
  33. Osuji N, Beiske K, Randen U, Matutes E, Tjonnfjord G, Catovsky D, Wotherspoon A (2007)
    Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia
    Histopathology, 50 (5), 547-54
    PubMed 17394489
  34. Rand-Hendriksen S, Tjeldhorn L, Lundby R, Semb SO, Offstad J, Andersen K, Geiran O, Paus B (2007)
    Search for correlations between FBN1 genotype and complete Ghent phenotype in 44 unrelated Norwegian patients with Marfan syndrome
    Am J Med Genet A, 143A (17), 1968-77
    PubMed 17663468
  35. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    PubMed 17853407
  36. Strauss G, Osen W, Knape I, Jacobsen EM, Müller SM, Debatin KM (2007)
    Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
    Cell Death Differ, 14 (3), 480-8
    PubMed 16902496
  37. Tchaikovski SN, van Vliet HA, Thomassen MC, Bertina RM, Rosendaal FR, Sandset PM, Helmerhorst FM, Tans G, Rosing J (2007)
    Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography
    Thromb Haemost, 98 (6), 1350-6
    PubMed 18064335
  38. Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
    Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
    Leukemia, 21 (10), 2203-4
    PubMed 17525727
  39. Tjønnfjord GE, Holme PA (2007)
    Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
    Vasc Health Risk Manag, 3 (4), 527-31
    PubMed 17969383
  40. Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S (2007)
    Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
    J Antimicrob Chemother, 59 (4), 711-7
    PubMed 17327294
  41. Villa I, Kvale EO, Lund-Johansen F, Olweus J (2007)
    Assay for monitoring in vitro selective depletion strategies in allogeneic stem cell transplantation
    Cytotherapy, 9 (6), 600-10
    PubMed 17882725
  42. Wisløff F (2007)
    [Epoetin in cancer treatment--the end of the game?]
    Tidsskr Nor Laegeforen, 127 (18), 2359
    PubMed 17895937
  43. Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2007)
    Serum calcium is an independent predictor of quality of life in multiple myeloma
    Eur J Haematol, 78 (1), 29-34
    PubMed 17038019

Publications 2006

  1. Austbø L, Espenes A, Olsaker I, Press CM, Skretting G (2006)
    Lymphoid follicles of the ileal Peyer's patch of lambs express low levels of PrP, as demonstrated by quantitative real-time RT-PCR on microdissected tissue compartments, in situ hybridization and immunohistochemistry
    J Gen Virol, 87 (Pt 11), 3463-71
    PubMed 17030883
  2. Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sørbø JH, Tjønnfjord GE (2006)
    Primary chronic cold agglutinin disease: a population based clinical study of 86 patients
    Haematologica, 91 (4), 460-6
    PubMed 16585012
  3. Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E (2006)
    Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
    Haematologica, 91 (5), 667-70
    PubMed 16670072
  4. Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
    Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
    J Thromb Haemost, 4 (8), 1840-2
    PubMed 16879232
  5. Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
    Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
    Br J Haematol, 132 (3), 333-8
    PubMed 16409298
  6. Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
    Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
    BMC Cardiovasc Disord, 6, 40
    PubMed 17029634
  7. Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2006)
    Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
    Thromb Res, 118 (2), 281-7
    PubMed 16139333
  8. Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM (2006)
    Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation
    Maturitas, 55 (3), 278-87
    PubMed 16713143
  9. Enden T, Kløw NE, Sandset PM (2006)
    [Catheter-directed thrombolysis in acute deep venous thrombosis]
    Tidsskr Nor Laegeforen, 126 (13), 1765
    PubMed 16794675
  10. Farkas L, Kvale EO, Lund-Johansen F, Jahnsen FL (2006)
    Plasmacytoid dendritic cells induce a distinct cytokine pattern in virus-specific CD4+ memory T cells that is modulated by CpG oligodeoxynucleotides
    Scand J Immunol, 64 (4), 404-11
    PubMed 16970682
  11. Frangu M, Gedde-Dahl T, Verder H (2006)
    [Epidermolysis bullosa simplex Dowling-Meara]
    Ugeskr Laeger, 168 (48), 4222-4
    PubMed 17147951
  12. Ghanima W, Abdelnoor M, Mowinckel MC, Sandset PM (2006)
    The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism
    Br J Haematol, 132 (2), 210-5
    PubMed 16398655
  13. Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
    Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
    Clin Exp Immunol, 144 (3), 418-24
    PubMed 16734610
  14. Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G (2006)
    Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
    Eur Heart J, 27 (9), 1038-47
    PubMed 16476694
  15. Jacobsen EM, Trettenes EJ, Wisløff F, Abildgaard U (2006)
    Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
    Thromb J, 4, 3
    PubMed 16436199
  16. Jensen T, Retterstøl LJ, Sandset PM, Godal HC, Skjønsberg OH (2006)
    A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial
    Blood Coagul Fibrinolysis, 17 (6), 471-6
    PubMed 16905951
  17. Jønsson V (2006)
    [Inheritance and cancer]
    Ugeskr Laeger, 168 (24), 2327
    PubMed 16822411
  18. Jønsson V, Bock JE, Hilden J, Houlston RS, Wiik A (2006)
    The influence of pregnancy on the development of autoimmunity in chronic lymphocytic leukemia
    Leuk Lymphoma, 47 (8), 1481-7
    PubMed 16966257
  19. Jønsson V, Johannesen TB (2006)
    Anticipation in lymphoproliferative disorders
    Leuk Lymphoma, 47 (10), 2015-6
    PubMed 17071471
  20. Jønsson V, Olsen JH (2006)
    [Inheritance in lymphoproliferative disorders]
    Ugeskr Laeger, 168 (24), 2361-6
    PubMed 16822421
  21. Kildahl-Andersen O, Thorstensen K, Sagen E, Dahl IM, Tjønnfjord G (2006)
    [A 40-year-old woman with anemia]
    Tidsskr Nor Laegeforen, 126 (22), 2958-9
    PubMed 17144048
  22. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2006)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    PubMed 16269620
  23. Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wislöff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Brinch L, Hammerström J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Nordic Myeloma Study Group (2006)
    Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
    Haematologica, 91 (9), 1228-33
    PubMed 16956822
  24. Lenhoff S, Hjorth M, Westin J, Brinch L, Bäckström B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerström J, Johnsen HE, Juliusson G, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I, Nordic Myeloma Study Group (2006)
    Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group
    Br J Haematol, 133 (4), 389-96
    PubMed 16643445
  25. Lotfi K, Karlsson K, Fyrberg A, Juliusson G, Jonsson V, Peterson C, Eriksson S, Albertioni F (2006)
    The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
    Biochem Pharmacol, 71 (6), 882-90
    PubMed 16436271
  26. Mathisen B, Loennechen T, Gedde-Dahl T, Winberg JO (2006)
    Fibroblast heterogeneity in collagenolytic response to colchicine
    Biochem Pharmacol, 71 (5), 574-83
    PubMed 16378602
  27. Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
    Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
    J Clin Oncol, 24 (17), 2683-4; author reply 2684
    PubMed 16763285
  28. Njaastad AM, Abildgaard U (2006)
    Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity
    J Intern Med, 260 (6), 596
    PubMed 17116014
  29. Njaastad AM, Abildgaard U, Lassen JF (2006)
    Gains and losses of warfarin therapy as performed in an anticoagulation clinic
    J Intern Med, 259 (3), 296-304
    PubMed 16476107
  30. O'Donnell MJ, Berge E, Sandset PM (2006)
    Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
    Stroke, 37 (2), 452-5
    PubMed 16410483
  31. Osuji N, Matutes E, Tjonnfjord G, Grech H, Del Giudice I, Wotherspoon A, Swansbury JG, Catovsky D (2006)
    T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature
    Cancer, 107 (3), 570-8
    PubMed 16795070
  32. Roed KH, Hasle G, Midthjell V, Skretting G, Leinaas HP (2006)
    Identification and characterization of 17 microsatellite primers for the tick, Ixodes ricinus, using enriched genomic libraries
    Mol. Ecol. Notes, 6 (4), 1165-1167
  33. Ruland C, Røslien J, Bakken S, Kristiansen J (2006)
    Comparing tailored computerized symptom assessments to interviews and questionnaires
    AMIA Annu Symp Proc, 1081
    PubMed 17238700
  34. Sandset PM (2006)
    Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions
    J Thromb Haemost, 4 (1), 68-9
    PubMed 16409452
  35. Sandset PM (2006)
    [How to make warfarin treatment successful?]
    Tidsskr Nor Laegeforen, 126 (2), 187
    PubMed 16415945
  36. Schneppenheim R, Kremer Hovinga JA, Becker T, Budde U, Karpman D, Brockhaus W, Hrachovinová I, Korczowski B, Oyen F, Rittich S, von Rosen J, Tjønnfjord GE, Pimanda JE, Wienker TF, Lämmle B (2006)
    A common origin of the 4143insA ADAMTS13 mutation
    Thromb Haemost, 96 (1), 3-6
    PubMed 16807643
  37. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    PubMed 17049554
  38. Smith A, Wisloff F, Samson D, UK Myeloma Forum, Nordic Myeloma Study Group, British Committee for Standards in Haematology (2006)
    Guidelines on the diagnosis and management of multiple myeloma 2005
    Br J Haematol, 132 (4), 410-51
    PubMed 16412016
  39. Tjeldhorn L, Rand-Hendriksen S, Gervin K, Brandal K, Inderhaug E, Geiran O, Paus B (2006)
    Rapid and efficient FBN1 mutation detection using automated sample preparation and direct sequencing as the primary strategy
    Genet Test, 10 (4), 258-64
    PubMed 17253931
  40. Tjønnfjord GE (2006)
    Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA
    Semin Hematol, 43 (2 Suppl 4), S18-21
    PubMed 16690372
  41. Aamot HV, Tjønnfjord GE, Delabie J, Heim S (2006)
    Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14)
    Cancer Genet Cytogenet, 165 (2), 172-5
    PubMed 16527613

Publications 2005

  1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
    Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
    Haematologica, 90 (1), 86-93
    PubMed 15642674
  2. Andresen MS, Abildgaard U (2005)
    Coagulation Inhibitor Potential: a study of assay variables
    Thromb Res, 115 (6), 519-26
    PubMed 15792684
  3. Crowther MA, Wisloff F (2005)
    Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis
    Thromb Res, 115 (1-2), 3-8
    PubMed 15567446
  4. Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
    A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
    J Thromb Haemost, 3 (4), 651-8
    PubMed 15842349
  5. de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
    Determinants of the APTT- and ETP-based APC sensitivity tests
    J Thromb Haemost, 3 (7), 1488-94
    PubMed 15978106
  6. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
    The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
    Maturitas, 52 (2), 111-8
    PubMed 16186073
  7. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T (2005)
    A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
    J Thromb Haemost, 3 (5), 848-53
    PubMed 15869575
  8. Ghanima W, Almaas V, Aballi S, Dörje C, Nielssen BE, Holmen LO, Almaas R, Abdelnoor M, Sandset PM (2005)
    Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study
    J Thromb Haemost, 3 (9), 1926-32
    PubMed 16102097
  9. Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005)
    Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
    Leukemia, 19 (12), 2159-65
    PubMed 16224487
  10. Guren TK, Christoffersen T, Thoresen GH, Wisløff F, Dajani O, Tveit KM (2005)
    [Antineoplastic agents targeting tyrosine kinases]
    Tidsskr Nor Laegeforen, 125 (22), 3115-9
    PubMed 16299568
  11. Haram K, Björge L, Sandset PM (2005)
    Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndrome: a case report
    Acta Obstet Gynecol Scand, 84 (12), 1213-4
    PubMed 16305714
  12. Hippe E, Westin J, Wislöff F (2005)
    Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care
    Eur J Haematol, 74 (3), 185-93
    PubMed 15693787
  13. Holme PA, Brosstad F, Tjønnfjord GE (2005)
    Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies
    Haemophilia, 11 (5), 510-5
    PubMed 16128896
  14. Iversen PO, Wiig H (2005)
    Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis
    Clin Cancer Res, 11 (19 Pt 1), 6793-9
    PubMed 16203766
  15. Jädersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellström-Lindberg E (2005)
    Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
    Blood, 106 (3), 803-11
    PubMed 15840690
  16. Jønsson V, Houlston RS, Catovsky D, Yuille MR, Hilden J, Olsen JH, Fajber M, Brandt B, Sellick G, Allinson R, Wiik A (2005)
    CLL family 'Pedigree 14' revisited: 1947-2004
    Leukemia, 19 (6), 1025-8
    PubMed 15800670
  17. Liestøl S, Wisløff F (2005)
    Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays
    Thromb Res, 115 (6), 509-17
    PubMed 15792683
  18. Mishra V, Andresen S, Brinch L, Kvaløy S, Ernst P, Lønset MK, Tangen JM, Wikelund J, Flatum C, Baggerød E, Helle B, Vaaler S, Hagen TP (2005)
    Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
    Bone Marrow Transplant, 35 (12), 1149-53
    PubMed 15880133
  19. Mishra V, Paus AC, Tjønnfjord GE (2005)
    [Surgery in patients with bleeding disorders--expensive treatment for a small group of patients]
    Tidsskr Nor Laegeforen, 125 (7), 883-5
    PubMed 15815735
  20. Negaard H, Dahm A, Sandset PM, Iversen PO, Ostenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr. Drug Targets, 6 (6), 681-699
  21. Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr Drug Targets, 6 (6), 683-99
    PubMed 16178801
  22. Reitan JB, Brinch L, Beiske K (2005)
    Multi-organ failure aspects of a fatal radiation accident in Norway in 1982
    BJR Suppl, 27, 36-40
    PubMed 15975870
  23. Schulman S, Tjønnfjord GE, Wallensten R, Martinowitz U, Kenet G (2005)
    Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII
    Thromb Haemost, 94 (6), 1177-80
    PubMed 16411390
  24. Sellick GS, Webb EL, Allinson R, Matutes E, Dyer MJ, Jonsson V, Langerak AW, Mauro FR, Fuller S, Wiley J, Lyttelton M, Callea V, Yuille M, Catovsky D, Houlston RS (2005)
    A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci
    Am J Hum Genet, 77 (3), 420-9
    PubMed 16080117
  25. Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N (2005)
    A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility
    Scand J Infect Dis, 37 (6-7), 455-64
    PubMed 16012006
  26. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    PubMed 16178798
  27. Tjønnfjord GE (2005)
    [Polycythemia vera]
    Tidsskr Nor Laegeforen, 125 (19), 2649
    PubMed 16273739
  28. Tjønnfjord GE (2005)
    [Anticoagulation therapy and oral surgery]
    Tidsskr Nor Laegeforen, 125 (21), 2999; author reply 2999
    PubMed 16276400
  29. Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR (2005)
    [Analysis of prothrombin time in primary health care]
    Tidsskr Nor Laegeforen, 125 (15), 2048-9
    PubMed 16100552
  30. Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P (2005)
    Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
    Eur J Haematol, 75 (4), 293-8
    PubMed 16146535
  31. Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, Jacobsen SE (2005)
    IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells
    J Immunol, 174 (2), 752-7
    PubMed 15634895

Publications 2004

  1. Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
    The ability of three global plasma assays to recognize thrombophilia
    Thromb Res, 113 (6), 411-7
    PubMed 15226097
  2. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, Ghanima W, Shammas FV, Tjønnfjord GE (2004)
    Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
    Blood, 103 (8), 2925-8
    PubMed 15070665
  3. Brodin E, Børvik T, Sandset PM, Bønaa KH, Nordøy A, Hansen JB (2004)
    Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study
    Thromb Haemost, 92 (1), 178-84
    PubMed 15213859
  4. Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B (2004)
    Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models
    Cancer Immunol Immunother, 53 (9), 759-69
    PubMed 15088126
  5. Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F (2004)
    Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides
    J Allergy Clin Immunol, 114 (2), 436-43
    PubMed 15316529
  6. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
    [Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
    Tidsskr Nor Laegeforen, 124 (6), 768-70
    PubMed 15039804
  7. Ghanima W, Kahrs J, Dahl TG, Tjonnfjord GE (2004)
    Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
    Eur J Haematol, 72 (6), 441-3
    PubMed 15128424
  8. Gniadecki R, Rossen K, Ralfkier E, Thomsen K, Skovgaard GL, Jønsson V (2004)
    CD56+ lymphoma with skin involvement: clinicopathologic features and classification
    Arch Dermatol, 140 (4), 427-36
    PubMed 15096371
  9. Gulbrandsen N, Hjermstad MJ, Wisløff F, Nordic Myeloma Study Group (2004)
    Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences
    Eur J Haematol, 72 (3), 172-80
    PubMed 14962235
  10. Heldal D, Brinch L, Evensen SA, Tjønnfjord GE, Aamodt G, Elgjo K, Sviland L (2004)
    Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow
    Bone Marrow Transplant, 34 (4), 345-50
    PubMed 15170163
  11. Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004)
    A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation
    Bone Marrow Transplant, 34 (3), 257-66
    PubMed 15170167
  12. Hjort PF, Sandset PM, Abildgaard U, Rao LV, Mast A, Ott I, Bajaj SP (2004)
    Tissue factor pathway inhibitor revisited
    J Thromb Haemost, 2 (12), 2241-9
    PubMed 15613032
  13. Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM (2004)
    Deep vein thrombosis after elective cesarean section
    Thromb Res, 113 (5), 283-8
    PubMed 15183039
  14. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjønsberg OH (2004)
    The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen
    Thromb Res, 113 (1), 51-6
    PubMed 15081565
  15. Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, Vahlquist A, Dahl N (2004)
    Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13
    J Med Genet, 41 (3), 208-12
    PubMed 14985385
  16. Koss-Harnes D, Høyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B, Wiche G, Gedde-Dahl T (2004)
    Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation
    Acta Derm Venereol, 84 (2), 124-31
    PubMed 15206692
  17. Lindahl TL, Egberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
    INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
    Thromb Haemost, 91 (6), 1223-31
    PubMed 15175811
  18. Lund MB, Brinch L, Kongerud J, Boe J (2004)
    Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide
    Eur Respir J, 23 (6), 901-5
    PubMed 15219005
  19. Ly B, Njaastad AM, Sandbaek G, Solstrand R, Rosales A, Slagsvold CE (2004)
    [Catheter-directed thrombolysis of iliofemoral venous thrombosis]
    Tidsskr Nor Laegeforen, 124 (4), 478-80
    PubMed 14983192
  20. Lyngstadaas A, Husebekk A, Funderud S, Brinch L (2004)
    [Clinical use of haematopoietic stem cells from cord blood]
    Tidsskr Nor Laegeforen, 124 (22), 2928-31
    PubMed 15550970
  21. Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J, Gringeri A, Joao-Diniz M, Lopaciuk S, Negrier C, Quintana M, Tagariello G, Tjonnfjord GE, Villar VA, Vorlova Z (2004)
    Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement
    Haemophilia, 10 Suppl 2, 50-2
    PubMed 15385047
  22. Russell D, Thomassen L, Indredavik B, Sandset PM, Joakimsen O, Berge E (2004)
    [Patients with acute brain infarction should receive thrombolytic therapy]
    Tidsskr Nor Laegeforen, 124 (12), 1666-7
    PubMed 15229721
  23. Sandset PM (2004)
    [Risk of venous thrombosis and smoking]
    Tidsskr Nor Laegeforen, 124 (15), 1937
    PubMed 15318411
  24. Sandset PM, Abildgaard U (2004)
    Tissue factor pathway inhibitor revisited
    J. Thromb. Haemost., 2 (12), 2242-2243
  25. Solberg EE, Ekeberg O, Holen A, Ingjer F, Sandvik L, Standal PA, Vikman A (2004)
    Hemodynamic changes during long meditation
    Appl Psychophysiol Biofeedback, 29 (3), 213-21
    PubMed 15497620
  26. Tiercy JM, Passweg J, van Biezen A, Zander A, Kröger N, Gratwohl A, Chapuis B, Helg C, Brinch L, Cornelissen J, Oudshoorn M, Ruutu T, Volin L, Niederwieser D, Roosnek E, Chronic Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT) (2004)
    Isolated HLA-C mismatches in unrelated donor transplantation for CML
    Bone Marrow Transplant, 34 (3), 249-55
    PubMed 15195077
  27. Tjønnfjord GE (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience
    Haemophilia, 10 Suppl 2, 41-5
    PubMed 15385045
  28. Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
    Haemophilia, 10 (2), 174-8
    PubMed 14962207
  29. Wisløff F (2004)
    [Total survival as quality indicator]
    Tidsskr Nor Laegeforen, 124 (23), 3096; author reply 3096
    PubMed 15586201
  30. Wisløff F, Crowther M (2004)
    Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure
    Thromb Res, 114 (2), 75-81
    PubMed 15306148
  31. Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, Hjorth M, Nielsen JL, Lenhoff S, Westin J, Wislöff F, Nordic Myeloma Study Group (2004)
    Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
    Br J Haematol, 125 (2), 149-55
    PubMed 15059136

Publications 2003

  1. Amundsen HF, Stray-Pedersen A, Tjønnfjord GE, Abrahamsen TG (2003)
    [Patients with severe chronic neutropenia]
    Tidsskr Nor Laegeforen, 123 (5), 621-3
    PubMed 12683187
  2. Amundsen HF, Stray-Pedersen A, Tjønnfjord GE, Abrahamsen TG (2003)
    [Chronic neutropenia--subtypes and treatment]
    Tidsskr Nor Laegeforen, 123 (5), 624-6
    PubMed 12683188
  3. Astermark J, Voorberg J, Lenk H, DiMichele D, Shapiro A, Tjönnfjord G, Berntorp E (2003)
    Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro
    Haemophilia, 9 (5), 567-72
    PubMed 14511295
  4. Bendz B, Sandset PM (2003)
    Acute hypoxia and activation of coagulation
    Lancet, 362 (9388), 997-8
    PubMed 14511938
  5. Bergheim J, Ernst P, Brinch L, Gore DM, Chetty MC, Stewart GW (2003)
    Allogeneic bone marrow transplantation for severe post-splenectomy thrombophilic state in leaky red cell membrane haemolytic anaemia of the stomatocytosis class
    Br J Haematol, 121 (1), 119-22
    PubMed 12670341
  6. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
    Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
    Blood, 101 (11), 4387-92
    PubMed 12560220
  7. Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM (2003)
    Epidermal growth factor receptor inhibition induces trichomegaly
    Acta Oncol, 42 (4), 345-6
    PubMed 12899508
  8. Dybedal I, Yang L, Bryder D, Aastrand-Grundstrom I, Leandersson K, Jacobsen SE (2003)
    Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
    Blood, 102 (1), 118-26
    PubMed 12637333
  9. Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J (2003)
    A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
    Leuk Res, 27 (4), 323-8
    PubMed 12531223
  10. Haram K, Trovik J, Sandset PM, Hordnes K (2003)
    Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome
    Acta Obstet Gynecol Scand, 82 (7), 679-80
    PubMed 12790854
  11. Hast R, Hellström-Lindberg E, Ohm L, Björkholm M, Celsing F, Dahl IM, Dybedal I, Gahrton G, Lindberg G, Lerner R, Linder O, Löfvenberg E, Nilsson-Ehle H, Paul C, Samuelsson J, Tangen JM, Tidefelt U, Turesson I, Wahlin A, Wallvik J, Winquist I, Oberg G, Bernell P (2003)
    No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease
    Leukemia, 17 (9), 1827-33
    PubMed 12970783
  12. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Albrechtsen D, Aamodt G, Evensen SA (2003)
    Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
    Bone Marrow Transplant, 32 (3), 257-64
    PubMed 12858196
  13. Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Löfvenberg E, Oberg G, Porwit-MacDonald A, Rådlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F, Scandinavian MDS Group (2003)
    A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life
    Br J Haematol, 120 (6), 1037-46
    PubMed 12648074
  14. Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S (2003)
    The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation
    Psychooncology, 12 (8), 803-13
    PubMed 14681953
  15. Iversen PO, Wisløff F (2003)
    [Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 304-7
    PubMed 12640894
  16. Jacobsen AF, Qvigstad E, Sandset PM (2003)
    Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
    BJOG, 110 (2), 139-44
    PubMed 12618157
  17. Lundin J, Hagberg H, Repp R, Cavallin-Ståhl E, Fredén S, Juliusson G, Rosenblad E, Tjønnfjord G, Wiklund T, Osterborg A (2003)
    Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
    Blood, 101 (11), 4267-72
    PubMed 12543862
  18. Mishra V, Vaaler S, Brinch L (2003)
    Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma
    Clin Lab Haematol, 25 (3), 179-84
    PubMed 12755795
  19. Nazir M, Stien R, Carlsen E, Jacobsen AF, Nesheim BI (2003)
    Early evaluation of bowel symptoms after primary repair of obstetric perineal rupture is misleading: an observational cohort study
    Dis Colon Rectum, 46 (9), 1245-50
    PubMed 12972970
  20. Normann AP, Egeland T, Madshus IH, Heim S, Tjønnfjord GE (2003)
    CD7 expression by CD34+ cells in CML patients, of prognostic significance?
    Eur J Haematol, 71 (4), 266-75
    PubMed 12950236
  21. Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
    Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
    J Intern Med, 253 (2), 232-9
    PubMed 12542565
  22. Schaadt BK, Hendel HW, Gimsing P, Jønsson V, Pedersen H, Hesse B (2003)
    99mTc-aprotinin scintigraphy in amyloidosis
    J Nucl Med, 44 (2), 177-83
    PubMed 12571206
  23. Thomassen L, Sandset PM, Joakimsen O, Indredavik B, Russell D (2003)
    [Intravenous thrombolytic therapy of patients with acute cerebral infarction]
    Tidsskr Nor Laegeforen, 123 (5), 638-9
    PubMed 12683192
  24. Virtanen M, Smith SK, Gedde-Dahl T, Vahlquist A, Bowden PE (2003)
    Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis
    J Invest Dermatol, 121 (5), 1013-20
    PubMed 14708600
  25. Wisløff F (2003)
    [Financing of enzyme treatment in Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 364
    PubMed 12640908
  26. Wisløff F, Brinch L, Hammerstrøm J (2003)
    [National guidelines for treatment of chronic myelogenous leukemia]
    Tidsskr Nor Laegeforen, 123 (2), 157-9
    PubMed 12607495

Publications 2002

  1. Andresen MS, Iversen N, Abildgaard U (2002)
    Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin
    Thromb Res, 108 (5-6), 323-8
    PubMed 12676193
  2. Bendz B, Sandset PM (2002)
    [Air travel and venous thrombosis]
    Tidsskr Nor Laegeforen, 122 (16), 1579-81
    PubMed 12119787
  3. Bendz B, Sandset PM (2002)
    Air travel and risk of venous thromboembolism
    Thromb Res, 108 (1), 15-7
    PubMed 12586126
  4. Dalgaard J, Brinch L, Tjønnfjord GE (2002)
    [Paroxysmal nocturnal hemoglobinuria--a rare disease with many faces]
    Tidsskr Nor Laegeforen, 122 (4), 374-8
    PubMed 11915665
  5. Ghanima W, Heldal D, Tjønnfjord GE (2002)
    [Hairy cell leukemia treated with cladribine]
    Tidsskr Nor Laegeforen, 122 (11), 1094-7
    PubMed 12043051
  6. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, Albrechtsen D, Aamodt G, Evensen SA (2002)
    Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
    Bone Marrow Transplant, 29 (6), 479-86
    PubMed 11960266
  7. Holte H, Smeland S, Blystad AK, Kvaløy S, Hammerstrøm J, Tjønnfjord GE (2002)
    [Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma]
    Tidsskr Nor Laegeforen, 122 (4), 364-9
    PubMed 11915663
  8. Itälä M, Geisler CH, Kimby E, Juvonen E, Tjonnfjord G, Karlsson K, Remes K (2002)
    Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study
    Eur J Haematol, 69 (3), 129-34
    PubMed 12406005
  9. Iversen N, Brandtzaeg P, Sandset PM, Kierulf P, Abildgaard U (2002)
    TFPI fractions in plasma from patients with systemic meningococcal disease
    Thromb Res, 108 (5-6), 347-53
    PubMed 12676197
  10. Iversen N, Lindahl AK, Abildgaard U (2002)
    Elevated plasma levels of the factor Xa-TFPI complex in cancer patients
    Thromb Res, 105 (1), 33-6
    PubMed 11864704
  11. Iversen PO, De Groot P, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
    Attenuated diurnal oscillations of pro-thrombotic markers in tetraplegia
    REPORTS FROM THE 17TH INTERNATIONAL CONGRESS ON THROMBOSIS, 59-62
  12. Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
    Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
    Br J Haematol, 119 (4), 1011-6
    PubMed 12472582
  13. Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P (2002)
    Involvement of plasmacytoid dendritic cells in human diseases
    Hum Immunol, 63 (12), 1201-5
    PubMed 12480264
  14. Jensen T, Halvorsen S, Godal HC, Skjønsberg OH (2002)
    Influence of freeze-drying on the clotting properties of fibrinogen in plasma
    Thromb Res, 105 (6), 499-502
    PubMed 12091049
  15. Jønsson V, Bock JE, Mortensen TH, Staun M, Thorsen S (2002)
    [Pregnancy-related thrombocytosis]
    Ugeskr Laeger, 164 (34), 3946-9
    PubMed 12212474
  16. Keating MJ, Cazin B, Coutré S, Birhiray R, Kovacsovics T, Langer W, Leber B, Maughan T, Rai K, Tjønnfjord G, Bekradda M, Itzhaki M, Hérait P (2002)
    Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed
    J Clin Oncol, 20 (1), 205-13
    PubMed 11773171
  17. Koss-Harnes D, Høyheim B, Anton-Lamprecht I, Gjesti A, Jørgensen RS, Jahnsen FL, Olaisen B, Wiche G, Gedde-Dahl T (2002)
    A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations
    J Invest Dermatol, 118 (1), 87-93
    PubMed 11851880
  18. Lehne G, Sørensen DR, Tjønnfjord GE, Beiske C, Hagve TA, Rugstad HE, Clausen OP (2002)
    The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
    Leukemia, 16 (12), 2388-94
    PubMed 12454743
  19. Liestøl S, Jacobsen EM, Wisløff F (2002)
    Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin
    Thromb Res, 105 (2), 177-82
    PubMed 11958810
  20. Lind B, Gedde-Dahl T, Tjønnfjord G, Villoutreix BO, Brosstad F (2002)
    Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation
    Thromb Haemost, 88 (4), 632-8
    PubMed 12362235
  21. Mishra V, Tjønnfjord GE, Paus AC, Vaaler S (2002)
    Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure
    Haemophilia, 8 (6), 809-14
    PubMed 12410652
  22. Mortensen TB, Jønsson V, Wiik A, Bock JE (2002)
    [Forty four pregnancies with idiopathic thrombocytopenic purpura]
    Ugeskr Laeger, 164 (34), 3968-72
    PubMed 12212479
  23. Müller F, Tjønnfjord GE, Nordøy I, Kvale D, Mellbye OJ, Aukrust P, Frøland SS (2002)
    Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
    Eur J Clin Invest, 32 (7), 535-40
    PubMed 12153555
  24. Nazir M, Carlsen E, Jacobsen AF, Nesheim BI (2002)
    Is there any correlation between objective anal testing, rupture grade, and bowel symptoms after primary repair of obstetric anal sphincter rupture?: an observational cohort study
    Dis Colon Rectum, 45 (10), 1325-31
    PubMed 12394430
  25. Os I, Os A, Sandset PM, Bølling S, Seljeflot I, Djurovic S, Westheim A (2002)
    Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
    Cardiology, 98 (1-2), 6-12
    PubMed 12373040
  26. Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, Bertz H, Ljungman P, Spence D, Verdonck LF, Prentice HG, Bosi A, Du Toit CE, Brinch L, Apperley JF, EBMT Chronic Leukaemia Working Party (2002)
    Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
    Br J Haematol, 118 (4), 1112-9
    PubMed 12199793
  27. Sandset PM (2002)
    [Anticoagulant therapy with warfarin--still difficult]
    Tidsskr Nor Laegeforen, 122 (10), 992
    PubMed 12082707
  28. Sandset PM, Abildgaard U (2002)
    Perioperative management of oral anticoagulant therapy
    Thromb Res, 108 (1), 1-2
    PubMed 12586124
  29. Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, Sundan A, Waage A, Seidel C (2002)
    Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
    Blood, 100 (12), 3925-9
    PubMed 12393395
  30. Van Maldergem L, Magré J, Khallouf TE, Gedde-Dahl T, Delépine M, Trygstad O, Seemanova E, Stephenson T, Albott CS, Bonnici F, Panz VR, Medina JL, Bogalho P, Huet F, Savasta S, Verloes A, Robert JJ, Loret H, De Kerdanet M, Tubiana-Rufi N, Mégarbané A, Maassen J, Polak M, Lacombe D, Kahn CR et al. (2002)
    Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
    J Med Genet, 39 (10), 722-33
    PubMed 12362029
  31. Wisløff F, Jacobsen EM, Liestøl S (2002)
    Laboratory diagnosis of the antiphospholipid syndrome
    Thromb Res, 108 (5-6), 263-71
    PubMed 12676184

Publications 2001

  1. Andresen PA, Gedde-Dahl T, Fausa O, Eide TJ, Heiberg A (2001)
    [Genetic analysis in familial adenomatous polyposis]
    Tidsskr Nor Laegeforen, 121 (1), 64-8
    PubMed 12013617
  2. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2001)
    Hypobaric hypoxia - Reply
    Lancet, 357 (9260), 955-956
  3. Bendz B, Sandset PM (2001)
    Deep-vein thrombosis in long-haul flights
    Lancet, 358 (9284), 837-8; author reply 839
    PubMed 11570398
  4. Bendz B, Sevre K, Andersen TO, Sandset PM (2001)
    Low molecular weight heparin prevents activation of coagulation in a hypobaric environment
    Blood Coagul Fibrinolysis, 12 (5), 371-4
    PubMed 11505080
  5. Berentsen S, Tjønnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Løkkevik E, Sørbø JH, Ulvestad E (2001)
    Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
    Br J Haematol, 115 (1), 79-83
    PubMed 11722415
  6. Berge E, Fjaertoft H, Indredavik B, Sandset PM (2001)
    Validity and reliability of simple questions in assessing short- and long-term outcome in Norwegian stroke patients
    Cerebrovasc Dis, 11 (4), 305-10
    PubMed 11385209
  7. Berge E, Friis P, Sandset PM (2001)
    Hemostatic activation in acute ischemic stroke
    Thromb Res, 101 (2), 13-21
    PubMed 11342202
  8. Berge E, Nakstad PH, Sandset PM, HAEST Study Group (2001)
    Large middle cerebral artery infarctions and the hyperdense middle cerebral artery sign in patients with atrial fibrillation
    Acta Radiol, 42 (3), 261-8
    PubMed 11350283
  9. Berge E, Sandset PM (2001)
    Heparin and aspirin in stroke
    Lancet, 357 (9261), 1044-5
    PubMed 11293624
  10. Bryder D, Ramsfjell V, Dybedal I, Theilgaard-Mönch K, Högerkorp CM, Adolfsson J, Borge OJ, Jacobsen SE (2001)
    Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation
    J Exp Med, 194 (7), 941-52
    PubMed 11581316
  11. Dearden CE, Matutes E, Cazin B, Tjønnfjord GE, Parreira A, Nomdedeu B, Leoni P, Clark FJ, Radia D, Rassam SM, Roques T, Ketterer N, Brito-Babapulle V, Dyer MJ, Catovsky D (2001)
    High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
    Blood, 98 (6), 1721-6
    PubMed 11535503
  12. Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE (2001)
    Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
    Blood, 98 (6), 1782-91
    PubMed 11535512
  13. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL (2001)
    Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions
    Am J Pathol, 159 (1), 237-43
    PubMed 11438470
  14. Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J, Nordic Myeloma Study Group (2001)
    Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
    Med Oncol, 18 (1), 65-77
    PubMed 11778972
  15. Gulbrandsen N, Wisløff F, Nord E, Lenhoff S, Hjorth M, Westin J, Nordic Myeloma Study Group (2001)
    Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma
    Eur J Haematol, 66 (5), 328-36
    PubMed 11422413
  16. Hansen JB, Grimsgaard S, Huseby N, Sandset PM, Bønaa KH (2001)
    Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
    Thromb Res, 102 (1), 3-13
    PubMed 11323009
  17. Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM (2001)
    Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial
    Br J Haematol, 115 (2), 415-20
    PubMed 11703344
  18. Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM (2001)
    The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial
    Thromb Haemost, 85 (5), 775-81
    PubMed 11372667
  19. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F (2001)
    The evaluation of clotting times in the laboratory detection of lupus anticoagulants
    Thromb Res, 104 (4), 275-82
    PubMed 11728529
  20. Jonkers IJ, de Man FH, van Tilburg NH, van der Laarse A, Sandset PM, Smelt AH, Bertina RM (2001)
    Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy
    Blood Coagul Fibrinolysis, 12 (8), 705-12
    PubMed 11734672
  21. Jorulf H, Finnbogason T, Jönsson V, Ringertz H (2001)
    Pediatric PACS, Astrid Lindgren Children's Hospital at Karolinska Hospital, Stockholm, technical and practical aspects
    Comput Methods Programs Biomed, 66 (1), 25-30
    PubMed 11378218
  22. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ, Brinch L, Brune M, De La Camara R, Dekker A, Pauksen K, Russell N, Schwarer AP, Cordonnier C (2001)
    Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 28 (5), 479-84
    PubMed 11593321
  23. Magré J, Delépine M, Khallouf E, Gedde-Dahl T, Van Maldergem L, Sobel E, Papp J, Meier M, Mégarbané A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F et al. (2001)
    Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
    Nat Genet, 28 (4), 365-70
    PubMed 11479539
  24. Melsom T, Brinch L, Hessen JO, Schei MA, Kolstrup N, Jacobsen BK, Svanes C, Pandey MR (2001)
    Asthma and indoor environment in Nepal
    Thorax, 56 (6), 477-81
    PubMed 11359965
  25. Mishra V, Vaaler S, Brinch L (2001)
    A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures
    Bone Marrow Transplant, 28 (12), 1111-6
    PubMed 11803351
  26. Nordal EJ, Mecklenbeck S, Hausser I, Skranes J, Bruckner-Tuderman L, Gedde-Dahl T (2001)
    Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets
    Br J Dermatol, 144 (1), 151-7
    PubMed 11167698
  27. Ringsted C, Schroeder TV, Henriksen J, Ramsing B, Lyngdorf P, Jønsson V, Scherpbier A (2001)
    Medical students' experience in practical skills is far from stakeholders' expectations
    Med Teach, 23 (4), 412-416
    PubMed 12098390
  28. Skotheim RI, Kraggerud SM, Fosså SD, Stenwig AE, Gedde-Dahl T, Danielsen HE, Jakobsen KS, Lothe RA (2001)
    Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence
    Neoplasia, 3 (3), 196-203
    PubMed 11494113
  29. van Leusden MR, Pas HH, Gedde-Dahl T, Sonnenberg A, Jonkman MF (2001)
    Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation
    Lab Invest, 81 (6), 887-94
    PubMed 11406649
  30. Virtanen M, Gedde-Dahl T, Mörk NJ, Leigh I, Bowden PE, Vahlquist A (2001)
    Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression
    Acta Derm Venereol, 81 (3), 163-70
    PubMed 11558869
  31. Wisløff F (2001)
    [Should iron preparations be available only on prescription?]
    Tidsskr Nor Laegeforen, 121 (9), 1155-6
    PubMed 11354901
  32. Wisløff F (2001)
    [Use of blood from patients with hemochromatosis]
    Tidsskr Nor Laegeforen, 121 (12), 1448
    PubMed 11449762
  33. Wisløff F, Tangen JM, Brinch L, Dahl IM, Gruber FX, Hammerstrøm J, Waage A, Nesthus I, Ernst P (2001)
    [High dose therapy with autologous stem cell support--finally a progress in myelomatosis]
    Tidsskr Nor Laegeforen, 121 (20), 2402-6
    PubMed 11603051

Publications 2000

  1. Bendz B, Andersen TO, Sandset PM (2000)
    A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
    Thromb Res, 97 (6), 463-72
    PubMed 10704656
  2. Bendz B, Andersen TO, Sandset PM (2000)
    Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
    Blood Coagul Fibrinolysis, 11 (4), 343-8
    PubMed 10847421
  3. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2000)
    Association between acute hypobaric hypoxia and activation of coagulation in human beings
    Lancet, 356 (9242), 1657-8
    PubMed 11089830
  4. Berentsen S, Tjønnfjord GE, Shammas FV, Bergheim J, Hammerstrøm J, Langholm R, Ulvestad E (2000)
    No response to cladribine in five patients with chronic cold agglutinin disease
    Eur J Haematol, 65 (1), 88-90
    PubMed 10914950
  5. Berge E, Abdelnoor M, Nakstad PH, Sandset PM (2000)
    Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial
    Lancet, 355 (9211), 1205-10
    PubMed 10770301
  6. Berge E, Sandset PM (2000)
    Heparin versus aspirin in ischaemic stroke - Reply
    Lancet, 356 (9228), 505
  7. Bock JE, Jønsson V (2000)
    [Innate mechanisms during pregnancy]
    Ugeskr Laeger, 162 (3), 366-8
    PubMed 10680480
  8. Bruserud O, Tjønnfjord G, Gjertsen BT, Foss B, Ernst P (2000)
    New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients
    Stem Cells, 18 (5), 343-51
    PubMed 11007918
  9. Clausen OP, Olsen G, Tjønnfjord GE (2000)
    [Flow cytometry--use in cell biology and benefits in clinical medicine]
    Tidsskr Nor Laegeforen, 120 (4), 489-95
    PubMed 10833942
  10. Dalgaard J, Ritland S, Brinch L, Ikonomou IM (2000)
    [Mastocytosis--a review illustrated by two case reports]
    Tidsskr Nor Laegeforen, 120 (11), 1312-5
    PubMed 10868093
  11. Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
    DXYS267: DYS393 and its X chromosome counterpart
    Forensic Sci Int, 112 (2-3), 111-21
    PubMed 10940596
  12. Gudmundsdottir E, Jonasson F, Jonsson V, Stefánsson E, Sasaki H, Sasaki K (2000)
    "With the rule" astigmatism is not the rule in the elderly. Reykjavik Eye Study: a population based study of refraction and visual acuity in citizens of Reykjavik 50 years and older. Iceland-Japan Co-Working Study Groups
    Acta Ophthalmol Scand, 78 (6), 642-6
    PubMed 11167223
  13. Hansen JB, Naalsund T, Sandset PM, Svensson B (2000)
    Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin
    Thromb Res, 100 (5), 413-7
    PubMed 11150584
  14. Hansen JB, Svensson B, Sandset PM, Thijssen F (2000)
    Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
    Thromb Res, 100 (5), 389-96
    PubMed 11150580
  15. Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, Solheim BG, Evensen SA (2000)
    A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
    Bone Marrow Transplant, 25 (11), 1129-36
    PubMed 10849524
  16. Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
    The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
    Thromb Res, 98 (1), 19-27
    PubMed 10706930
  17. Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM (2000)
    Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)
    Thromb Haemost, 84 (6), 961-7
    PubMed 11154141
  18. Iversen N, Strekerud FG, Abildgaard U (2000)
    Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex
    Blood Coagul Fibrinolysis, 11 (7), 591-8
    PubMed 11085278
  19. Jacobsen AF, Qvigstad E, Sandset PM (2000)
    [Treatment of venous thromboembolism in pregnancy with low molecular weight heparin]
    Tidsskr Nor Laegeforen, 120 (20), 2448-9
    PubMed 11475236
  20. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F (2000)
    The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5
    Thromb Haemost, 83 (5), 704-8
    PubMed 10823266
  21. Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P (2000)
    Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy
    J Immunol, 165 (7), 4062-8
    PubMed 11034417
  22. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjøonsberg OH (2000)
    Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction
    Thromb Res, 100 (5), 397-403
    PubMed 11150581
  23. Jønsson V, Friis-Hansen LJ, Hou-Jensen K (2000)
    [Picture of the month. Splenomegaly with hereditary stomatocytosis]
    Ugeskr Laeger, 162 (31), 4158
    PubMed 10962920
  24. Jønsson V, Gemmell CG, Wiik A (2000)
    Emerging concepts in the management of the malignant haematological disorders
    Expert Opin Pharmacother, 1 (4), 713-35
    PubMed 11249512
  25. Jønsson V, Lyngdorf P, Bygum T, Jørgensen LG, Ringsted CV, Schroeder TV (2000)
    [Problem-based learning in medical education]
    Ugeskr Laeger, 162 (8), 1068-72
    PubMed 10741244
  26. Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen HE, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S (2000)
    Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group
    Blood, 95 (1), 7-11
    PubMed 10607678
  27. Lund-Johansen F, Davis K, Bishop J, de Waal Malefyt R (2000)
    Flow cytometric analysis of immunoprecipitates: high-throughput analysis of protein phosphorylation and protein-protein interactions
    Cytometry, 39 (4), 250-9
    PubMed 10738277
  28. Lund C, Rygh J, Stensrød B, Sandset PM, Brucher R, Russell D (2000)
    Cerebral microembolus detection in an unselected acute ischemic stroke population
    Cerebrovasc Dis, 10 (5), 403-8
    PubMed 10971027
  29. Molander S, Jønsson V, Andersen LP, Bennedsen M, Christiansen M, Hou-Jensen K, Madsen HO, Ryder LP, Permin H, Wiik A (2000)
    [Pseudolymphoma and ventricular maltoma in patients with chronic gastritis, ulcer and Helicobacter pylori infection]
    Ugeskr Laeger, 162 (6), 791-5
    PubMed 10689954
  30. Nordbø SA, Skaug K, Holter E, Waage A, Brinch L (2000)
    Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation
    Eur J Haematol, 65 (1), 86-7
    PubMed 10914949
  31. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H (2000)
    Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia
    Arterioscler Thromb Vasc Biol, 20 (1), 259-65
    PubMed 10634827
  32. Nordøy A, Bønaa KH, Sandset PM, Hansen JB, Nilsen H (2000)
    Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia
    Nutr Metab Cardiovasc Dis, 10 (1), 15-23
    PubMed 10812583
  33. Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland K, Larsen A, Midtbo K, Westheim A (2000)
    The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
    J Intern Med, 247 (4), 433-41
    PubMed 10792556
  34. Pigg M, Gedde-Dahl T, Cox DW, Haugen G, Dahl N (2000)
    Haplotype association and mutation analysis of the transglutaminase 1 gene for prenatal exclusion of lamellar ichthyosis
    Prenat Diagn, 20 (2), 132-7
    PubMed 10694685
  35. Sandset PM, Bendz B, Hansen JB (2000)
    Physiological function of tissue factor pathway inhibitor and interaction with heparins
    Haemostasis, 30 Suppl 2, 48-56
    PubMed 11251341
  36. Steen R, Tjønnfjord GE, Grøseth LA, Egeland T (2000)
    Characteristics of haemopoietic progenitor cells related to CD34 epitope class expression
    Eur J Haematol, 64 (4), 245-51
    PubMed 10776696
  37. Tangen JM (2000)
    [Alexander Pushkin's duel--biographic and medical aspects]
    Tidsskr Nor Laegeforen, 120 (10), 1170-2
    PubMed 10863347
  38. Wisløff F, Gulbrandsen N (2000)
    Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients. Nordic Myeloma Study Group
    Acta Oncol, 39 (7), 809-13
    PubMed 11145438